Phase II Trial of BrECADD in HIV-Positive Patients With Advanced-Stage Classical Hodgkin Lymphoma

Inclusion Criteria

• •Histologically confirmed first diagnosis of cHL
• •Advanced-stage disease: stage IIB with large mediastinal mass and/or extranodal lesions or stage III or IV
• •No previous treatment for HL with the exception of steroid prephase
• •Confirmed HIV infection with CD4 counts ≥ 150/μL at registration or \> 250/μL at any time within 8 months prior to HL diagnosis
• •Continuation of antiretroviral treatment (ART) / Initiation of ART in patients who are ART-naive
• •Age: 18-60 years